PBLSNASDAQHealthcare
PARABILIS MEDICINES INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$28.32
-1.32%
Alpha Vantage · 10/30/2026
Industry: BiotechnologyCategory: Domestic Common StockCurrency: USDNews: 0 recent
Analyze PBLS free One-year price history
Adjusted daily closes · 100 observations · as of Oct 30, 2026
1 month
-7.0%
3 months
-16.6%
6 months
—
1 year
-10.4%
Year to date
-10.4%
52-week range
$22.75 – $41.73
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$3.5B
P/E
-18.7
P/B
3.3
P/S
—
Revenue
—
Net income
—
Diluted EPS
—
Gross margin
—
Net margin
—
Return on equity
—
Total debt
$47.51M
Cash
$1.09B
Free cash flow
—
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $148K | -$52.46M | 100.00% | -45239.90% | -$4.24M |
| Mar 31, 2026 | $0 | -$45.32M | — | — | -$49.57M |
| Dec 31, 2025 | — | — | — | — | — |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent PBLS news
All market newsNo ticker-linked stories are in the current archive.